Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands reverse CTL suppression by alternatively activated (M2) macrophages in cancer

Blood
J A Van GinderachterPatrick De Baetselier

Abstract

Tumors may escape from immune control by the induction of CD11b(+)Gr-1(+) myeloid suppressor cells in the spleen. In this study, we demonstrate that this cell population can be subdivided into a CD11b(hi)Gr-1(int)SSC(lo)Ly6G(neg)M-CSFR(int) immature monocytic fraction and a CD11b(hi+)Gr-1(hi)SSC(hi)Ly6G(hi)M-CSFR(neg) granulocytic fraction. Upon in vitro culture, the monocytic CD11b(+)Gr-1(+) cell fraction is sufficient for cytotoxic T lymphocyte (CTL) suppression, which is linked to the gradual differentiation of these monocytic cells into mature F4/80(+) CD68(+) macrophages. These CTL-suppressive macrophages are alternatively activated (M2), as demonstrated by the expression of known and novel M2 signature genes. In search of M2-associated genes involved in the suppressive activity, it is shown that stimulation of peroxisome proliferator-activated receptor gamma (PPARgamma) and inhibition of phospholipase A(2) (PLA(2)) activity cooperate to alleviate CTL suppression. Of importance, purified tumor-associated macrophages display a similar M2 phenotype and are suppressive for antitumor CTLs, via a mechanism that can be almost completely reversed by PPARgamma ligands. Overall, our data identify PLA(2) and especially PPARgamma as ...Continue Reading

References

Oct 1, 1996·Critical Reviews in Clinical Laboratory Sciences·L MuszbekH Mikkola
Dec 10, 1996·Proceedings of the National Academy of Sciences of the United States of America·M P RamprasadD Steinberg
Sep 17, 1998·Journal of Leukocyte Biology·K D ElgertD W Mullins
May 5, 2000·Digestive Diseases and Sciences·G D'ArgenioP D Bishop
Dec 21, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·B AlmandD I Gabrilovich
Feb 27, 2001·Nature Immunology·Y LatchmanG J Freeman
Apr 21, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·D I GabrilovichW M Kast
Aug 18, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·M ThiviergeM Rola-Pleszczynski
Nov 21, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·M HesseT A Wynn
Feb 2, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kimiko WatanabeSara M Rankin
Sep 10, 2002·Trends in Endocrinology and Metabolism : TEM·Chih-Hao Lee, Ronald M Evans
Oct 3, 2002·Nature Reviews. Immunology·Raymond A Daynes, Dallas C Jones
Oct 29, 2002·FEBS Letters·Jesús BalsindeEdward A Dennis
Dec 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Vincenzo BrontePaola Zanovello
Jan 4, 2003·Nature Reviews. Immunology·Siamon Gordon
Apr 17, 2003·Proceedings of the National Academy of Sciences of the United States of America·P'ng Loke, James P Allison
May 8, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yuanqing LiuAnja B Geldhof
Jul 29, 2003·European Journal of Immunology·Philip R TaylorSiamon Gordon
Jul 30, 2003·Journal of Leukocyte Biology·Sergei Kusmartsev, Dmitry I Gabrilovich
Oct 22, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Stefan El-GayarChristian Bogdan
Dec 23, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yulia NefedovaDmitry Gabrilovich
Jan 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sergei KusmartsevDmitry I Gabrilovich
Feb 12, 2004·Cancer Research·Qingsheng LiShu-Hsia Chen
Mar 23, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Cord SunderkötterPieter J M Leenen
Mar 24, 2004·Trends in Parasitology·Wim NoëlAlain Beschin
Nov 9, 2004·Trends in Immunology·Alberto MantovaniMassimo Locati
Dec 2, 2004·Nature Reviews. Immunology·Dmitry Gabrilovich

❮ Previous
Next ❯

Citations

Aug 7, 2012·Cancer Immunology, Immunotherapy : CII·Stephanie K BuntMichael A Hollingsworth
Oct 26, 2011·Nature Reviews. Immunology·Toby Lawrence, Gioacchino Natoli
Mar 23, 2012·Nature Reviews. Immunology·Dmitry I GabrilovichVincenzo Bronte
Jan 26, 2011·Integrative Biology : Quantitative Biosciences From Nano to Macro·M Veiseh, E A Turley
Oct 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Daniela RuffellClaus Nerlov
Aug 29, 2012·The Journal of Experimental Medicine·Timothy O'SullivanJack D Bui
Dec 9, 2008·Antioxidants & Redox Signaling·Milton HamblinY Eugene Chen
Dec 17, 2009·American Journal of Physiology. Lung Cellular and Molecular Physiology·Vivek BalasubramaniamSteven H Abman
Feb 16, 2008·PPAR Research·Venkateshwar G KeshamouniJesse Roman
Jan 4, 2007·The Journal of Clinical Investigation·Carey N LumengAlan R Saltiel
May 4, 2007·The Journal of Clinical Investigation·Antonio Sica, Vincenzo Bronte
Sep 4, 2012·Vascular Cell·Michael C Schmid, Judith A Varner
Jun 8, 2014·Biochemical Pharmacology·Nhat D QuachBrian S Cummings
Jul 11, 2008·PPAR Research·Jo A Van GinderachterPatrick De Baetselier
Sep 29, 2012·Immunological Investigations·Nataša ObermajerPawel Kalinski
Sep 12, 2007·Expert Opinion on Therapeutic Targets·Antonio SicaAlberto Mantovani
Mar 1, 2011·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Ajaya Kumar RekaVenkateshwar G Keshamouni
Jul 14, 2007·Current Opinion in Immunology·Geert RaesPatrick De Baetselier
Aug 30, 2008·International Journal of Cancer. Journal International Du Cancer·Hisashi WadaEiichi Nakayama
Dec 8, 2007·Clinical and Experimental Immunology·C SchoenbeinR Sabat
Nov 10, 2010·European Journal of Immunology·Jo A Van GinderachterGeert Raes
Jul 11, 2012·Journal of Cellular Physiology·Guangwei Liu, Hui Yang
Nov 22, 2013·International Journal of Cancer. Journal International Du Cancer·Patrick L RaberPaulo C Rodriguez
Nov 18, 2014·Immunity, Inflammation and Disease·Simone Cardozo StoneAna Paula Lepique
Feb 9, 2012·Seminars in Cancer Biology·Srinivas Nagaraj, Dmitry I Gabrilovich
Dec 30, 2014·Frontiers in Oncology·Kim De VeirmanJo A Van Ginderachter
Feb 18, 2014·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Alexandros NikolaouJo A Van Ginderachter
Feb 16, 2018·Journal of Immunology Research·Ildefonso Alves da Silva JuniorAna Paula Lepique

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.